Neurocrine Biosciences, Inc.NBIXNASDAQ
LOADING
|||
Revenue Scaling
Trending higher, above historical average, strong compound growth.
Left:
||||
Total revenue from sales of goods and services
Latest
$2.36B
↑ 152% above average
Average (9y)
$934.62M
Historical baseline
Range
High:$2.36B
Low:$15.00M
CAGR
+70.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $2.36B | +24.8% |
| 2023 | $1.89B | +26.8% |
| 2022 | $1.49B | +31.3% |
| 2021 | $1.13B | +8.4% |
| 2020 | $1.05B | +32.7% |
| 2019 | $788.10M | +74.7% |
| 2018 | $451.20M | +179.2% |
| 2017 | $161.63M | +977.5% |
| 2016 | $15.00M | -24.1% |
| 2015 | $19.77M | - |